Trial Details
TERMINATEDBasic Information
| Clinical ID | c3333 |
|---|---|
| Identifier | NCT02209792 |
| Trial Title | Dose Finding Study of BIRB 796 BS in Patients With Moderate to Severe Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DRUG: Placebo|DRUG: BIBR 796 BS, 5 mg|DRUG: BIBR 796 BS, 20 mg |
Participant Information
| Sponsor | Boehringer Ingelheim |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2 |
Time Information
| Start Date | 2001-10 |
|---|---|
| Primary Completion Date | 2004-01 |
| Completion Date | - |